公司概覽
業務類別 Medical Devices
業務概覽 Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
公司地址 3222 Phoenixville Pike, Malvern, PA, USA, 19355
電話號碼 +1 877 600-7555
傳真號碼 +1 610 640-4206
公司網頁 https://www.neurostar.com
員工數量 658
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Daniel L. Reuvers Director, President and Chief Executive Officer -- 29/05/2026
Mr. Nir Naor Executive Vice President, Chief Financial Officer, Principal Accounting Officer and Corporate Secretary, and Treasurer -- 17/08/2026
Mr. Cory Anderson Executive Vice President and General Manager, Greenbrook -- 20/07/2026
 
董事會成員
董事會 職務 更新日期
Mr. Glenn P. Muir Independent Director 09/04/2026
Mr. Robert A. Cascella Non-Executive Chairman of the Board 09/04/2026
Ms. Sheryl L. Conley Independent Director 09/04/2026
Mr. Daniel L. Reuvers Director, President and Chief Executive Officer 29/05/2026
Mr. Sasha S. Cucuz Independent Director 09/04/2026
Ms. Megan R. Rosengarten Independent Director 09/04/2026
Dr. Avinash N. Amin, M.D. Independent Director 09/04/2026
 
所屬ETF (更新日期: 22/08/2026 04:30)
代號 名稱 佔比% ▼ 持有日期
PSILAdvisorShares Psychedelics ETF1.08%31/07/2026
IWCiShares Micro-Cap ETF0.12%31/07/2026
QQQSInvesco NASDAQ Future Gen 200 ETF0.10%31/07/2026
BUSMEA Bridgeway Ultra-Small Company Mkt ETF0.07%31/07/2026
RSSLGlobal X Russell 2000 ETF<0.000001%29/06/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.